Sequencing Therapies in Advanced Renal Cell Carcinoma

EP. 1: When to Start Systemic Treatment in Newly Diagnosed RCC

June 29th 2016

EP. 2: Goals of Therapy in Advanced RCC

June 29th 2016

EP. 3: Determining Initial Therapeutic Approach in Advanced RCC

June 29th 2016

EP. 4: Choosing Among TKIs in Advanced RCC

June 29th 2016

EP. 5: RCC First-Line Toxicity Considerations

June 29th 2016

EP. 6: Assessing Treatment Response with RCC First-Line Therapies

June 29th 2016

EP. 7: Advanced RCC Sequencing Challenges

June 29th 2016

EP. 8: Patient Selection and Checkpoint Inhibition in RCC

June 29th 2016

EP. 9: The Rationale for Cabozantinib in Advanced RCC

June 29th 2016

EP. 10: Options in the Third Line Setting for RCC

June 29th 2016

EP. 11: The Role of Lenvatinib in Advanced RCC

June 29th 2016

EP. 12: Second and Third-Line Decisions in RCC

June 29th 2016

EP. 13: Long-Term RCC Data with Nivolumab

June 29th 2016

EP. 14: Novel Approaches in Advanced RCC

June 29th 2016

EP. 15: A Changing Landscape in RCC

June 29th 2016

EP. 16: A Look to the Future in RCC

June 29th 2016